Search results
Gateway - The Root
The Root· 17 hours agoThe Biden administration is expected to announce this week that Americans who got the Pfizer-BioNTech or Moderna vaccines will need the third shot to protect ...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 5 days agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older ...
New COVID Mystery? Those 'Excess Deaths'
newser· 2 days agoCOVID vaccines "were provided to guard civilians," but didn't always work as advertised. Clinical trials showed that Pfizer and Moderna vaccine ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
The Kansas City Star· 5 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 21 hours agoCiting the 69-page lawsuit submitted to the District Court of Thomas County, Fox Business highlights that Pfizer misled the public by claiming its COVID-19 vaccine was safe ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Another COVID vaccine? Yes, and here’s why
Denver Post· 7 days agoLast Wednesday, FDA’s advisers, a panel of physicians from hospitals and universities around the nation, unanimously voted to recommend a new vaccine. ...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 4 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 5 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
